These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18501601)

  • 21. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.
    Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP
    DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc chloride stimulates DNA synthesis of mouse embryonic stem cells: involvement of PI3K/Akt, MAPKs, and mTOR.
    Ryu JM; Lee MY; Yun SP; Han HJ
    J Cell Physiol; 2009 Mar; 218(3):558-67. PubMed ID: 18988195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
    Kong D; Okamura M; Yoshimi H; Yamori T
    Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baicalein suppresses hypoxia-induced HIF-1alpha protein accumulation and activation through inhibition of reactive oxygen species and PI 3-kinase/Akt pathway in BV2 murine microglial cells.
    Hwang KY; Oh YT; Yoon H; Lee J; Kim H; Choe W; Kang I
    Neurosci Lett; 2008 Oct; 444(3):264-9. PubMed ID: 18771709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
    Zhang HY; Zhang PN; Sun H
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways.
    Lee MY; Jo SD; Lee JH; Han HJ
    J Cell Biochem; 2008 Dec; 105(6):1410-9. PubMed ID: 18980246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
    Serra V; Markman B; Scaltriti M; Eichhorn PJ; Valero V; Guzman M; Botero ML; Llonch E; Atzori F; Di Cosimo S; Maira M; Garcia-Echeverria C; Parra JL; Arribas J; Baselga J
    Cancer Res; 2008 Oct; 68(19):8022-30. PubMed ID: 18829560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma.
    Pomel V; Klicic J; Covini D; Church DD; Shaw JP; Roulin K; Burgat-Charvillon F; Valognes D; Camps M; Chabert C; Gillieron C; Françon B; Perrin D; Leroy D; Gretener D; Nichols A; Vitte PA; Carboni S; Rommel C; Schwarz MK; Rückle T
    J Med Chem; 2006 Jun; 49(13):3857-71. PubMed ID: 16789742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug discovery approaches targeting the PI3K/Akt pathway in cancer.
    Garcia-Echeverria C; Sellers WR
    Oncogene; 2008 Sep; 27(41):5511-26. PubMed ID: 18794885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
    Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
    Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phosphoinositide 3-kinase/Akt pathway involved in regulation of hypoxia inducible factor 1alpha in hypoxia ischemia brain damage of neonatal rats].
    Li L; Qu Y; Mao M; Mu D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Sep; 22(9):1102-7. PubMed ID: 18822739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin induces osteoprotegerin synthesis via phosphatidylinositol 3'-kinase/mammalian target of rapamycin pathway in human periodontal ligament cells.
    Arayatrakoollikit U; Pavasant P; Yongchaitrakul T
    J Periodontal Res; 2008 Oct; 43(5):537-43. PubMed ID: 18565131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons.
    Chen TJ; Wang DC; Chen SS
    J Neurosci Res; 2009 Aug; 87(10):2297-307. PubMed ID: 19301428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
    Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a small-molecule inhibitor of class Ia PI3Ks with cell-based screening.
    Yang J; Shamji A; Matchacheep S; Schreiber SL
    Chem Biol; 2007 Apr; 14(4):371-7. PubMed ID: 17462572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1alpha inhibitors.
    Boovanahalli SK; Jin X; Jin Y; Kim JH; Dat NT; Hong YS; Lee JH; Jung SH; Lee K; Lee JJ
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6305-10. PubMed ID: 17884495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practicalities of drugging the phosphatidylinositol-3-kinase/Akt cell survival signaling pathway.
    Powis G; Ihle N; Kirkpatrick DL
    Clin Cancer Res; 2006 May; 12(10):2964-6. PubMed ID: 16707590
    [No Abstract]   [Full Text] [Related]  

  • 38. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation.
    Bedogni B; Welford SM; Cassarino DS; Nickoloff BJ; Giaccia AJ; Powell MB
    Cancer Cell; 2005 Dec; 8(6):443-54. PubMed ID: 16338658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
    Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
    Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation.
    Li Q; Li T; Zhu GD; Gong J; Claibone A; Dalton C; Luo Y; Johnson EF; Shi Y; Liu X; Klinghofer V; Bauch JL; Marsh KC; Bouska JJ; Arries S; De Jong R; Oltersdorf T; Stoll VS; Jakob CG; Rosenberg SH; Giranda VL
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1679-85. PubMed ID: 16403626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.